Literature DB >> 25421471

Isolation of VIM-2-producing Pseudomonas monteilii clinical strains disseminated in a tertiary hospital in northern Spain.

Alain A Ocampo-Sosa1, Laura P Guzmán-Gómez2, Marta Fernández-Martínez2, Elena Román2, Cristina Rodríguez2, Francesc Marco3, Jordi Vila3, Luis Martínez-Martínez4.   

Abstract

We describe here the occurrence of blaVIM-2 in 10 carbapenem-resistant Pseudomonas monteilii strains isolated from different clinical samples from patients at the University Hospital Marqués de Valdecilla in northern Spain. All the blaVIM-2-harboring P. monteilii isolates possessed a class 1 integron, with the cassette array [intI1_blaVIM-2_aac(6')-Ib_qacEΔ1_sul1]. Our results show the emergence of VIM-2-producing multidrug-resistant species other than Pseudomonas aeruginosa or Pseudomonas putida in a Spanish hospital. P. monteilii, although sporadically isolated, should also be considered an important metallo-β-lactamase (MBL) reservoir.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25421471      PMCID: PMC4335825          DOI: 10.1128/AAC.04639-14

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  21 in total

1.  Achieving 100% typeability of Pseudomonas aeruginosa by pulsed-field gel electrophoresis.

Authors:  U Römling; B Tümmler
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

2.  Pseudomonas monteilii sp. nov., isolated from clinical specimens.

Authors:  M Elomari; L Coroler; S Verhille; D Izard; H Leclerc
Journal:  Int J Syst Bacteriol       Date:  1997-07

3.  On functional and structural heterogeneity of VIM-type metallo-beta-lactamases.

Authors:  Jean-Denis Docquier; Josette Lamotte-Brasseur; Moreno Galleni; Gianfranco Amicosante; Jean-Marie Frère; Gian Maria Rossolini
Journal:  J Antimicrob Chemother       Date:  2003-02       Impact factor: 5.790

Review 4.  [Carbapenemases in Pseudomonas spp].

Authors:  Carlos Juan Nicolau; Antonio Oliver
Journal:  Enferm Infecc Microbiol Clin       Date:  2010-01       Impact factor: 1.731

5.  Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme.

Authors:  Chi Hye Park; Ari Robicsek; George A Jacoby; Daniel Sahm; David C Hooper
Journal:  Antimicrob Agents Chemother       Date:  2006-09-05       Impact factor: 5.191

6.  Characterization of aminoglycoside-modifying enzymes in enterobacteriaceae clinical strains and characterization of the plasmids implicated in their diffusion.

Authors:  Elisenda Miró; Federico Grünbaum; Laura Gómez; Alba Rivera; Beatriz Mirelis; Pere Coll; Ferran Navarro
Journal:  Microb Drug Resist       Date:  2012-12-03       Impact factor: 3.431

Review 7.  Metallo-beta-lactamases: the quiet before the storm?

Authors:  Timothy R Walsh; Mark A Toleman; Laurent Poirel; Patrice Nordmann
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

8.  Identification of plasmids by PCR-based replicon typing.

Authors:  Alessandra Carattoli; Alessia Bertini; Laura Villa; Vincenzo Falbo; Katie L Hopkins; E John Threlfall
Journal:  J Microbiol Methods       Date:  2005-06-02       Impact factor: 2.363

9.  Beta-lactam and aminoglycoside resistance rates and mechanisms among Pseudomonas aeruginosa in French general practice (community and private healthcare centres).

Authors:  Véronique Dubois; Corinne Arpin; Virginie Dupart; Aline Scavelli; Laure Coulange; Catherine André; Isabelle Fischer; Frédéric Grobost; Jean-Philippe Brochet; Isabelle Lagrange; Brigitte Dutilh; Jacqueline Jullin; Patrick Noury; Gilberte Larribet; Claudine Quentin
Journal:  J Antimicrob Chemother       Date:  2008-05-08       Impact factor: 5.790

10.  Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals.

Authors:  O Gutiérrez; C Juan; E Cercenado; F Navarro; E Bouza; P Coll; J L Pérez; A Oliver
Journal:  Antimicrob Agents Chemother       Date:  2007-10-15       Impact factor: 5.191

View more
  6 in total

1.  Emergence of Carbapenem-Resistant Pseudomonas asiatica Producing NDM-1 and VIM-2 Metallo-β-Lactamases in Myanmar.

Authors:  Mari Tohya; Tatsuya Tada; Shin Watanabe; Kyoko Kuwahara-Arai; Khwar Nyo Zin; Ni Ni Zaw; May Yee Aung; San Mya; Khin Nyein Zan; Teruo Kirikae; Htay Htay Tin
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

2.  Exacerbation of bronchiectasis by Pseudomonas monteilii: a case report.

Authors:  Malini Shariff; Kiran Beri
Journal:  BMC Infect Dis       Date:  2017-07-24       Impact factor: 3.090

Review 3.  Antibiotic Resistant Pseudomonas Spp. Spoilers in Fresh Dairy Products: An Underestimated Risk and the Control Strategies.

Authors:  Laura Quintieri; Francesca Fanelli; Leonardo Caputo
Journal:  Foods       Date:  2019-09-01

4.  Comprehensive Genomic Survey of Antimicrobial-Resistance Bacteria in the Sewage Tank Replacement with Hospital Relocation.

Authors:  Miwa Katagiri; Makoto Kuroda; Tsuyoshi Sekizuka; Norihide Nakada; Yukitaka Ito; Masanobu Otsuka; Manabu Watanabe; Shinya Kusachi
Journal:  Infect Drug Resist       Date:  2021-12-20       Impact factor: 4.003

5.  VIM-encoding IncpSTY plasmids and chromosome-borne integrative and mobilizable elements (IMEs) and integrative and conjugative elements (ICEs) in Pseudomonas.

Authors:  Fangzhou Chen; Peng Wang; Zhe Yin; Huiying Yang; Lingfei Hu; Ting Yu; Ying Jing; Jiayao Guan; Jiahong Wu; Dongsheng Zhou
Journal:  Ann Clin Microbiol Antimicrob       Date:  2022-03-09       Impact factor: 3.944

6.  Genomic Epidemiology of MBL-Producing Pseudomonas putida Group Isolates in Poland.

Authors:  Paweł Urbanowicz; Radosław Izdebski; Marta Biedrzycka; Elżbieta Literacka; Waleria Hryniewicz; Marek Gniadkowski
Journal:  Infect Dis Ther       Date:  2022-06-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.